J&J Among Drug Makers Getting Chicago’s Opiates Suit Tossed

Lock
This article is for subscribers only.

Prescription painkiller makers including Johnson & Johnson and Actavis Plc won dismissal of Chicago’s lawsuit blaming them for drug addiction and higher medical costs.

Claims that patients were misled by Purdue Pharma Inc., the maker of OxyContin, were allowed to go forward, while a federal judge threw out allegations against J&J’s Janssen Pharmaceuticals unit, Teva Pharmaceutical Industries Ltd. and Endo Health Solutions Inc.